Clinical Outcomes In Patients With Non-Small-Cell Lung Cancer With Leptomeningeal Carcinomatosis

被引:0
|
作者
Takahashi, Y. [1 ]
Moriguchi, S. [1 ]
Ogawa, K. [1 ]
Murase, K. [1 ]
Mochizuki, S. [1 ]
Hanada, S. [1 ]
Uruga, H. [1 ]
Miyamoto, A. [1 ]
Takaya, H. [1 ]
Morokawa, N. [1 ]
Kurosaki, A. [2 ]
Fujii, T. [1 ]
Kishi, K. [1 ]
机构
[1] Toranomon Gen Hosp, Tokyo, Japan
[2] Fukujuji Hosp, Japan AntiTB Assoc, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4577
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Clinical Outcomes of Leptomeningeal Metastasis in Patients with Non-small Cell Lung Cancer in the Modern Era
    Park, Jin Hyun
    Kim, Yu Jung
    Lee, Jeong-Ok
    Lee, Keun-Wook
    Kim, Jee Hyun
    Bang, Soo-Mee
    Lee, Jong-Seok
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S397 - S397
  • [12] Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer
    Ko, Youngsan
    Gwak, Ho-Shin
    Park, Eun Young
    Joo, Jungnam
    Lee, Young Joo
    Lee, Sang Hyeon
    Kwon, Ji-Woong
    Shin, Sang-Hoon
    Yoo, Heon
    JOURNAL OF NEURO-ONCOLOGY, 2019, 143 (03) : 553 - 562
  • [13] Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer
    Otsubo, K.
    Seki, N.
    Nakanishi, Y.
    Okamoto, I.
    ANNALS OF ONCOLOGY, 2018, 29 (03) : 780 - 781
  • [14] Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer
    Youngsan Ko
    Ho-Shin Gwak
    Eun Young Park
    Jungnam Joo
    Young Joo Lee
    Sang Hyeon Lee
    Ji-Woong Kwon
    Sang-Hoon Shin
    Heon Yoo
    Journal of Neuro-Oncology, 2019, 143 : 553 - 562
  • [15] CLINICAL OUTCOMES IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER TREATED IN PHASE I CLINICAL TRIALS
    Janku, F.
    Gong, J.
    Garrido-Laguna, I.
    Parsons, H. A.
    Vaklavas, C.
    Kurzrock, R.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S86 - S86
  • [16] Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes
    Mu, Yuxin
    Hao, Xuezhi
    Xing, Puyuan
    Hu, Xingsheng
    Wang, Yan
    Li, Teng
    Zhang, Jinyao
    Xu, Ziyi
    Li, Junling
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2427 - 2433
  • [17] Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis
    Paz-Ares, Luis
    Soulieres, Denis
    Melezinek, Ivan
    Moecks, Joachim
    Keil, Lorenz
    Mok, Tony
    Rosell, Rafael
    Klughammer, Barbara
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (1-2) : 51 - 69
  • [18] Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes
    Yuxin Mu
    Xuezhi Hao
    Puyuan Xing
    Xingsheng Hu
    Yan Wang
    Teng Li
    Jinyao Zhang
    Ziyi Xu
    Junling Li
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2427 - 2433
  • [19] CLINICAL OUTCOMES OF LEPTOMENINGEAL METASTASIS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN THE MODERN CHEMOTHERAPY ERA
    Park, Jin Hyun
    Kim, Yu Jung
    Lee, Jeong-Ok
    Lee, Keun-Wook
    Kim, Jee Hyun
    Bang, Soo-Mee
    Chung, Jin-Haeng
    Kim, Jae Sung
    Lee, Jong Seok
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1205 - S1205
  • [20] Clinical Characteristics and Outcomes in Patients with Leptomeningeal Disease (LMD) from Non-Small Cell Lung Cancer
    Pan, K.
    Hong, L.
    Zhang, J.
    Byers, L. A.
    Gibbons, D. L.
    Heymach, J. V.
    Beckham, T. H.
    Ferguson, S. D.
    Le, X.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S344 - S344